Analysis

Patents A Key Focus As Drug-Pricing Debate Intensifies

Law360 (October 2, 2020, 8:42 PM EDT) -- There has been a flurry of legislative proposals taking aim at the perceived role of patents in driving up drug prices, and while no one idea has yet gained traction, experts expect drug patents to keep attracting bipartisan scrutiny well after the election.

Members of Congress on Wednesday took a panel of pharmaceutical executives to task about their prices at a heated hearing that underscored the strong feelings on the issue. Several lawmakers have been particularly focused on the practice of so-called evergreening, where a single drug is covered by more and more patents over time, which can cause long delays in...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!